DOCS — Doximity Cashflow Statement
0.000.00%
Last trade - 00:00- $10.63bn
- $9.78bn
- $475.42m
- 100
- 11
- 99
- 80
Annual cashflow statement for Doximity, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 29.7 | 50.2 | 155 | 113 | 148 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 8.86 | 14 | 47.9 | 64.3 | 59 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.2 | 10.1 | -39.9 | -21 | -24.1 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 26.2 | 83 | 127 | 180 | 184 |
| Capital Expenditures | -4.24 | -4.61 | -5.7 | -6.18 | -5.8 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -8.85 | -65.8 | -635 | -53.7 | 37 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -13.1 | -70.4 | -641 | -59.9 | 31.2 |
| Financing Cash Flow Items | 0 | -1.47 | -4.8 | -3.82 | -12.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 1.72 | 5.41 | 560 | -74.5 | -277 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 14.8 | 18 | 46.4 | 45.2 | -61.2 |